You are here

Zepbound

GLP-1 prescriptions for weight loss soar, despite obstacles

BioPharma Dive

Wed, 05/28/25 - 10:58 am

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

CNBC

Thu, 05/22/25 - 10:50 am

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial

Investing.com

Sun, 05/11/25 - 10:06 pm

clinical trials

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list

MSN/Reuters

Wed, 05/7/25 - 11:05 pm

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

CNBC

Wed, 04/23/25 - 11:01 am

compounded drugs

Patients scramble as cheaper obesity drug alternatives disappear

NPR

Thu, 03/20/25 - 11:15 am

compounding pharmacies

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

CNBC

Tue, 02/25/25 - 11:14 am

Wegovy and Ozempic stars dim amid overuse concerns

Axios

Tue, 02/11/25 - 11:17 am

Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say

Forbes

Fri, 01/31/25 - 10:59 am

New Zepbound TV Commercial Inspires ‘Change’

Xtalks

Wed, 01/29/25 - 07:25 pm

DTC advertising

Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's

Fierce Pharma

Tue, 01/21/25 - 07:13 pm

Alzheimer's disease

Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy

Fierce Pharma

Fri, 01/17/25 - 11:34 am

clinical trials

Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, Health Department agency says

CNBC

Wed, 01/8/25 - 11:07 pm

Use of diabetes and anti-obesity drugs surges nationwide

Axios

Fri, 01/3/25 - 10:07 am

Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver

Forbes

Wed, 01/1/25 - 10:49 pm

Zepbound, Mounjaro shortages are resolved, FDA confirms

BioPharma Dive

Thu, 12/19/24 - 09:36 pm

Eli Lilly is going to test Zepbound as a treatment for addiction

Quartz

Wed, 12/11/24 - 10:44 pm

alcohol-use disorder

Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro

Yahoo Finance

Wed, 12/11/24 - 11:01 am

Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial

BioPharma Dive

Wed, 12/4/24 - 11:02 am

clinical trials

Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms

Pharma Live

Tue, 12/3/24 - 11:36 am

Pages